MyFinsight
Home
About
Contact
Back
Income Statement
Acumen Pharmaceuticals, Inc. (ABOS)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$40,942K
Unrealized gain (loss) on
marketable securities
$8K
Interest income
$2,015K
Net loss
-$40,950K
Total other income
$800K
Change in fair value of
embedded derivatives
-$40K
Interest expense
$1,046K
Other expense, net
-$129K
Loss from operations
-$41,750K
Total operating
expenses
$41,750K
General and
administrative
$4,625K
Research and development
$37,125K
Back